doctor consulting with older patient

IMPACT OF OA

OA, the most common form of arthritis, affects more than 32.5M adults in the US. The prevalence of OA is expected to continue to increase as a result of aging, obesity and sports injuries.

Learn More
image of medicine vial

OUR PRODUCT

A non-opioid, extended-release, intra-articular injection that employs our proprietary microsphere technology to treat OA knee pain.

Read More
molecule image releasing microbeads

OUR SCIENCE

We are tireless in our pursuit of innovative science which holds the potential to transform the treatment of musculoskeletal conditions.

Learn More
lab tech using microscope

OUR PIPELINE

Flexion’s strategy is to build a robust pipeline of locally administered therapies to address musculoskeletal conditions, with an initial focus on OA, post-operative pain and low back pain.

See the Pipeline
group of people with hands in together

Join Our Team

Flexion Therapeutics prides itself on finding great talent, rewarding hard work and maintaining a culture that is unparalleled.

2019 BBJ Best Places to Work badge The Boston Globe Top Places to Work 2018

Learn More